Submitted by Jonathan Rosenblum on
"This was spin, and [the food industry] will have to get beyond that and make real changes or they'll get beat up again very soon." Perhaps a line from a nutritionist slamming the Better Business Bureaus' weak new voluntary restrictions on junk food marketing to kids? Instead, it's the president of MGP & Associates Public Relations, Mike Paul.
Submitted by Jonathan Rosenblum on
Public health charities are under intense pressure from potential or ongoing commercial sponsors to boost their budgets with product promotion schemes. For example, the American Diabetes Association (ADA) currently has a $1.5 million sponsorship deal with Cadbury Schweppes, maker of Dr. Pepper and the Cadbury Creme egg.
Submitted by Bob Burton on
On November 17 the U.S. Food and Drug Administration (FDA) approved silicone breast implants manufactured by Mentor Corporation and Allergan. PR Week reports that the PR firm MS&L "began working with Inamed Corp.
Submitted by Bob Burton on
The drug industry is bracing itself for major legislative changes once the new Congress sits. Forbes journalist Matthew Herper notes that, following the mid-term elections, major drug company shares have dropped by over 5%.
When PR Watch most recently caught a cell phone signal from Eric Schlosser, author of Fast Food Nation and the new Chew on This: Everything You Don't Want to Know About Fast Food, Schlosser was rushing from car to car in New York City, after London, which was just after Berkeley, where he was giving students a preview of the indie film version of "Fas
Submitted by Bob Burton on
Jim Rogers, the Chief Executive of Duke Energy, a power company that is keen to build nuclear power plants in North and South Carolina, told reporters at an energy conference that he was "cautiously optimistic on nuclear, but public opinion turns on a dime." The nuclear industry faces considerable hurdles.
Submitted by Bob Burton on
US Deputy Health Secretary, Alex Azar, is lobbying the Britain's Health Secretary, Patricia Hewitt, to ease restrictions on the drug industry. In particular, the U.S. drug companies want the ban on direct-to-consumer advertising dropped and to increase the prices the government pays for drugs.
Submitted by Bob Burton on
The Tobacco Manufacturers Association (TMA), a U.K.-based trade association, is lobbying against a European Union proposal to require companies to manufacture cigarettes that reduce the chances of causing a fire if not being smoked.
Submitted by Bob Burton on
Even though the European Medicines Agency has endorsed the use of Prozac and similar drugs in children over eight, medical researchers doubt the appropriateness of prescribing such powerful drugs in all but rare cases.
Submitted by Bob Burton on
Adriane Fugh-Berman, an Associate Professor at Georgetown University School of Medicine, recounts her experience of speaking at a recent medical conference in New Mexico on the topic of drug industry influence in medical education. "Immediately after my talk, one pharmaceutical company representative announced to a conference organiser that her company would no longer support the annual conference. Another packed up his exhibit and walked out," she writes in the British Medical Journal.
Center for Media and Democracy (CMD)
520 University Ave, Ste 305 • Madison, WI 53703 • (608) 260-9713
CMD is a 501(c)(3) tax-exempt non-profit.
© 1993-2024